![](/images/general/no_picture/200_user.png)
Carl D Friedman
Examiner (ID: 6600)
Most Active Art Unit | 3504 |
Art Unit(s) | 2403, 2407, 3635, 3621, 3505, 3632, 3504 |
Total Applications | 1006 |
Issued Applications | 891 |
Pending Applications | 6 |
Abandoned Applications | 109 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17329257
[patent_doc_number] => 11219698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Metal oxide nanoparticle-based T1-T2 dual-mode magnetic resonance imaging contrast agent
[patent_app_type] => utility
[patent_app_number] => 16/933198
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4272
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933198 | Metal oxide nanoparticle-based T1-T2 dual-mode magnetic resonance imaging contrast agent | Jul 19, 2020 | Issued |
Array
(
[id] => 16806202
[patent_doc_number] => 20210128755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => TARGETING LIGANDS FOR TAU PATHOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/922762
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922762 | TARGETING LIGANDS FOR TAU PATHOLOGY | Jul 6, 2020 | Abandoned |
Array
(
[id] => 16862722
[patent_doc_number] => 11021451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/916817
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16889
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16916817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/916817 | Contrast agents | Jun 29, 2020 | Issued |
Array
(
[id] => 16776378
[patent_doc_number] => 20210113455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Encapsulation of Microbubbles Within the Aqueous Core of Microcapsules
[patent_app_type] => utility
[patent_app_number] => 16/887974
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887974 | Encapsulation of microbubbles within the aqueous core of microcapsules | May 28, 2020 | Issued |
Array
(
[id] => 16805904
[patent_doc_number] => 20210128457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES
[patent_app_type] => utility
[patent_app_number] => 16/876109
[patent_app_country] => US
[patent_app_date] => 2020-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876109 | METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES | May 16, 2020 | Pending |
Array
(
[id] => 16389679
[patent_doc_number] => 20200330620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => TARGETED GAS-FILLED MICROVESICLES FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/867685
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16867685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/867685 | Targeted gas-filled microvesicles formulation | May 5, 2020 | Issued |
Array
(
[id] => 16808060
[patent_doc_number] => 20210130613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => POSITIVELY CHARGED NANOPARTICLES, USE THEREOF, AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/855547
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855547 | POSITIVELY CHARGED NANOPARTICLES, USE THEREOF, AND PREPARATION METHOD THEREOF | Apr 21, 2020 | Pending |
Array
(
[id] => 16204945
[patent_doc_number] => 20200237935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/851585
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851585 | Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16175593
[patent_doc_number] => 20200222561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Ultrasound Gel Composition
[patent_app_type] => utility
[patent_app_number] => 16/834871
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834871 | Ultrasound Gel Composition | Mar 29, 2020 | Abandoned |
Array
(
[id] => 16178192
[patent_doc_number] => 20200225160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS AND SYSTEMS FOR SPATIALLY IDENTIFYING ABNORMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/829498
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829498 | Methods and systems for spatially identifying abnormal cells | Mar 24, 2020 | Issued |
Array
(
[id] => 16153507
[patent_doc_number] => 20200214986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
[patent_app_type] => utility
[patent_app_number] => 16/823058
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823058 | Rapidly disintegrating gelatinous coated tablets | Mar 17, 2020 | Issued |
Array
(
[id] => 16153507
[patent_doc_number] => 20200214986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
[patent_app_type] => utility
[patent_app_number] => 16/823058
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823058 | Rapidly disintegrating gelatinous coated tablets | Mar 17, 2020 | Issued |
Array
(
[id] => 16304196
[patent_doc_number] => 10772967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Enhanced anticancer agent
[patent_app_type] => utility
[patent_app_number] => 16/784971
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 25383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784971 | Enhanced anticancer agent | Feb 6, 2020 | Issued |
Array
(
[id] => 16204947
[patent_doc_number] => 20200237937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/773512
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773512 | COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY | Jan 26, 2020 | Pending |
Array
(
[id] => 16252231
[patent_doc_number] => 20200261605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/751943
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 380
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751943 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | Jan 23, 2020 | Abandoned |
Array
(
[id] => 15863157
[patent_doc_number] => 20200138982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE
[patent_app_type] => utility
[patent_app_number] => 16/730029
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730029 | RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE | Dec 29, 2019 | Abandoned |
Array
(
[id] => 17426951
[patent_doc_number] => 20220054659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/312548
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312548 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | Dec 12, 2019 | Pending |
Array
(
[id] => 17385572
[patent_doc_number] => 20220033424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FLUOROUS METAL CHELATES COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/311299
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311299 | FLUOROUS METAL CHELATES COMPOSITIONS | Dec 8, 2019 | Pending |
Array
(
[id] => 17503563
[patent_doc_number] => 20220096665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/296129
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296129 | BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING | Nov 19, 2019 | Pending |
Array
(
[id] => 16451114
[patent_doc_number] => 20200360540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 16/688540
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688540 | FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION | Nov 18, 2019 | Abandoned |